Diovan recall (Novartis Pharmaceuticals Corporation)
DrugClass IIOngoing
Summary: Novartis Pharmaceuticals Corporation is recalling Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34. Reason: Failed Dissolution Specifications.
What is being recalled
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
Why
Failed Dissolution Specifications
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
US Nationwide
How to tell if yours is affected
Lot AV5913C, Expiry: 6/2027
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0746-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | August 4, 2026 |
| Reported | August 19, 2026 |
| Company | Novartis Pharmaceuticals Corporation |
| Company location | East Hanover, NJ, United States |
| Initiated by | Voluntary: Firm initiated |
More recalls from Novartis Pharmaceuticals Corporation · all drug recalls · recalls from August 2026